Adalimumab Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

China Pharmaceutical Excipients Industry Report, 2014-2017

China Pharmaceutical Excipients Industry Report, 2014-2017

  • $ 2 300
  • Industry report
  • by Research In China
  • November 2014
  • 101 pages

Pharmaceutical excipients refer to adjuvants and additives used for production of pharmaceuticals and compounding of prescriptions. In addition to active ingredients, pharmaceutical excipients are also contained in pharmaceutical preparations after reasonable safety assessment. China has launched more ...

Industries: Drug and Medication | Countries: China

Cancer Drug News 17 NOVEMBER 2014

Cancer Drug News 17 NOVEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • November 2014
  • 12 pages

Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology Industry Brief - First Patient Dosed In NeuVax+Herceptin Phase II Trial Industry Brief - Pooled Data Show OS Benefit Of Halaven In HER2/Triple-Negative BC Industry Brief - FDA Removes Full Clinical Hold ...

Industries: Drug and Medication

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 104 pages

BMI View: While we lowered our projections for Hungary's pharmaceutical industry in response to the government's structural reform programme at the start of 2011, we continue to believe the reported magnitude of the cuts to drug subsidies will not be achievable. Our scepticism over the credibility of ...

Industries: Drug and Medication | Countries: Hungary

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 110 pages

BMI View: Latvia’s attractiveness to multinationals will continue to be negatively impacted by the government’s cost-containment measures and the wider macroeconomic performance, especially as much of pharmaceutical spending is sourced out of pocket. The difficult conditions in their home industry ...

Industries: Drug and Medication | Countries: Latvia

Japan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Japan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 154 pages

BMI View: Japan’s pharmaceutical industry is proving to be a welcome refuge for the leading multinational drugmakers, which are experiencing austerity-induced revenue contractions in Western Europe and healthcare reform costs in the US. Despite numerous operating challenges in Japan, most notably delays ...

Industries: Drug and Medication | Countries: Japan

Jordan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Jordan Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 110 pages

BMI View: Regionally speaking, Jordan’s pharmaceutical industry will continue to be viewed as a moderately attractive destination for foreign drugmakers. The country has a well-developed local pharmaceutical market, which has allowed it to maintain a positive trade balance, and a broadly acceptable ...

Industries: Drug and Medication | Countries: Jordan

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 111 pages

BMI View: The introduction of a revised claw-back mechanism in Romania has angered drugmakers operating in the industry . BMI believes the current form of the legislation is overly simplistic and punishes drug suppliers in excess of their original exposure. Although it is highly unlikely the market will ...

Industries: Drug and Medication | Countries: Romania

Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • November 2014
  • 102 pages

BMI View: Under pressure from jittery financial industries, a new Italian government led by Prime Minister Mario Monti was sworn in on November 16 2011, just four days after the resignation of Silvio Berlusconi. The austerity measures expected in the coming months include the likely reintroduction of ...

Industries: Drug and Medication | Countries: Italy

Africa: Ginger - Market Report. Analysis and Forecast to 2020

Africa: Ginger - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the African Market of Ginger. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics and food balance. The report shows the sales data, allowing you to identify the key drivers and restraints. ...

Industries: Drug and Medication | Countries: Africa

Asia: Ginger - Market Report. Analysis and Forecast to 2020

Asia: Ginger - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • November 2014

The report provides an in-depth analysis of the Asian Market of Ginger. It presents the latest data of the market value, consumption, domestic production, exports and imports, price dynamics and food balance. The report shows the sales data, allowing you to identify the key drivers and restraints. You ...

Industries: Drug and Medication | Countries: Asia

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.